Evidence map›Paper›PMID 31492016›Full record

ArticleNutrients2019

Soluble CD14 in Breast Milk and Its Relation to Atopic Manifestations in Early Infancy.

Bahrul Fikri, Yumi Tani, Kazue Nagai, Masumi Sahara, Chisako Mitsuishi, Yaei Togawa, Taiji Nakano, Fumiya Yamaide, Hiroshi Ohno, Naoki Shimojo

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Probiotics in infants for prevention of allergic disease.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Bahrul FikriDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba 2608670, Japan.
Yumi TaniDepartment of Pediatrics, Japanese Red Cross Katsushika Maternity Hospital, Tokyo 1240012, Japan.
Kazue NagaiResearch and Education Center of Health Sciences, Gunma University Graduate School of Health Sciences, Gunma 3718510, Japan.ORCID 0000-0002-2562-2127
Masumi SaharaDepartment of Pediatrics, Japanese Red Cross Katsushika Maternity Hospital, Tokyo 1240012, Japan.
Chisako MitsuishiDepartment of Pediatrics, Japanese Red Cross Katsushika Maternity Hospital, Tokyo 1240012, Japan.
Yaei TogawaDepartment of Dermatology, Graduate School of Medicine, Chiba University, Chiba 2608670, Japan.
Taiji NakanoDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba 2608670, Japan.
Fumiya YamaideDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba 2608670, Japan.ORCID 0000-0002-2916-9710
Hiroshi OhnoRIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa 2300045, Japan.
Naoki ShimojoDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba 2608670, Japan. shimojo@faculty.chiba-u.jp.
Chiba University · JPJapanese Red Cross Katsushika Maternity Hospital · JPGunma University · JPRIKEN Center for Integrative Medical Sciences · JP

Funding

Japan Agency for Medical Research and Development J17JK00057 and J17JK00058
6 · The paper itself

Abstract

Soluble CD14 (sCD14) is one of the immunomodulatory factors in breast milk (BM). Although it may be involved in the prevention of atopic symptoms and sensitization to both food and inhalant allergens, conflicting evidence exists concerning its protective effects. In this study, we investigated the relationship between sCD14 in colostrum and 1-month BM, and the development of atopic dermatitis (AD) and sensitization to food and aeroallergens at 9 months of age in infants who were exclusively or almost exclusively breastfed up to 4 months of age. BM samples were collected from lactating mothers who participated in a 2 × 2 factorial, randomized, nontreatment controlled trial study set in Tokyo, which looked at the efficacy of emollients and synbiotics in preventing AD and food allergy in children during the first year of life. A total of 258 colostrum samples and 269 1-month BM samples were analyzed. We found that one-month BM sCD14 levels in the AD group were significantly lower than in the non-AD group. Levels of sCD14 in 1-month BM were not related to allergen sensitization in the overall analysis, but egg white sensitization correlated inversely with 1-month BM sCD14 in infants without AD. The results suggest that sCD14 in BM may be involved in atopic manifestations in early infancy.

Indexed as

Breast FeedingAdultAge FactorsColostrumDermatitis, AtopicFemaleFood HypersensitivityHumansInfantLipopolysaccharide ReceptorsMaleMilk, HumanProtective FactorsRandomized Controlled Trials as TopicRisk FactorsTokyoCD14 protein, humanLipopolysaccharide Receptorsallergen sensitizationatopic dermatitisbreast milksoluble CD14

Identifiers

PMID31492016
PMCPMC6770418
OpenAlexW2971419193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.